제주대학교 의과대학 의학사
경북대학교 의과대학 의학석사
서울대학교 의과대학 의학박사 수료
병무청 중앙신체검사소 병역판정검사전담의사
분당서울대학교병원 소화기내과 임상강사
분당서울대학교병원 소화기내과 진료전문의
계명대학교 동산병원 소화기내과 조교수
한림대학교성심병원 소화기내과 임상조교수
대한내과학회 정회원, 소화기내과 분과전문의
대한소화기내시경학회 정회원, 내시경 세부전문의
대한췌장담도학회 평생회원, 췌장담도내시경(ERCP) 인증의/지도전문의
대한소화기암학회 평생회원, 소화기암 인정의, 췌장담도암 위원회 위원
대한소화기내시경학회 우수논문상 (2018.11.18.)
대한췌장담도학회 추계학술대회 우수포스터상 (2019.09.21.)
대한췌장담도학회(IC-KBPA 2020) 우수구연상 (2020.08.08.)
Shin DW, Lee JC, Kim J, Yoon YS, Han HS, Kim H, et al. Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial. Pancreatology. 2021;21(4):796-804.
Shin DW, Kim MJ, Lee JC, Kim J, Woo SM, Lee WJ, et al. Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study. Am J Clin Oncol. 2020;43(6):422-7.
Shin DW, Lee JC, Kim J, Woo SM, Lee WJ, Han SS, et al. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2019;45(11):2159-65.
Shin DW, Choi YJ, Kim HS, Han KD, Yoon H, Park YS, et al. Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea. Dis Colon Rectum. 2018;61(11):1250-7.
Shin DW, Yoon H, Kim HS, Choi YJ, Shin CM, Park YS, et al. Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study. Evid Based Complement Alternat Med. 2018;2018:9147914.
Shin DW, Hwang HY, Jeon SW. Comparison of Endoscopic Submucosal Dissection and Surgery for Differentiated Type Early Gastric Cancer within the Expanded Criteria. Clin Endosc. 2017;50(2):170-8.
Shin DW, Kim MA, Lee JC, Kim J, Hwang JH. Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients. BMC Res Notes. 2021;14(1):272.
Hwang YJ, Shin DW, Kim N, Yoon H, Shin CM, Park YS, et al. Sex difference in bowel preparation quality and colonoscopy time. Korean J Intern Med. 2021;36(2):322-31.
Lee JC, Woo SM, Shin DW, Kim J, Yang SY, Kim MJ, et al. Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry. Am J Clin Oncol. 2020;43(9):654-9.
Lee JC, Shin DW, Park H, Kim J, Youn Y, Kim JH, et al. Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial. Gastrointest Endosc. 2020;92(5):1044-52.e1.
Cho JH, Yoon YS, Kim EJ, Kim YS, Cho JY, Han HS, Park YH, Shin DW, Lee JC, Hwang JH, Kim J. A multicenter prospective randomized controlled trial for preoperative biliary drainage with uncovered metal versus plastic stents for resectable periampullary cancer. J Hepatobiliary Pancreat Sci. 2020;27(10):690-9.
Ahn S, Lee JC, Shin DW, Kim J, Hwang JH. High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer. Sci Rep. 2020;10(1):12348.
Choi YJ, Lee DH, Shin DW, Han KD, Yoon H, Shin CM, et al. Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study. Aliment Pharmacol Ther. 2019;50(7):769-79.
Song DH, Cho IK, Shin DW, Lee JC, Cho JY, Yoon YS, et al. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer. Surg Today. 2021;51(6):978-85.
Kim HS, Choi YJ, Shin DW, Han KD, Yoon H, Shin CM, et al. Secondary Primary Prostate Cancer after Colorectal Cancer: A Nationwide Population-based Cohort Study in Korea. J Cancer Prev. 2017;22(4):241-7.
Jung JH, Shin DW, Kim J, Lee JC, Hwang JH. Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment. Cancers (Basel). 2020;12(11).
Kim HS, Yoon H, Shin DW, Oh DJ, Kwon M, Choi YJ, Shin CM, Park YS, Kim N, Lee DH Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Helicobacter pylori Eradication. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020;20(3):218-224.